Skip to main content
XERS logo
XERS
(NASDAQ)
Xeris Biopharma Holdings, Inc.
$6.79-- (--)
Loading... - Market loading

Xeris Biopharma Holdings (XERS) Stock Price & Financial Analysis

Xeris Biopharma Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$6.79 - $7.08
52-Week High$10.08
52-Week Low$4.30
Open$7.07
Volume1.63M
Average Volume (3M)1.73M
Market Cap1.21B
Shares Outstanding180.07M
P/E Ratio (TTM)2181.02
Price to Sales (P/S)4.14
Price to Book (P/B)88.27
EV/EBITDA33.43
Revenue (TTM)291.85M
Net Income (TTM)554.00K
Free Cash Flow (TTM)27.64M
EPS (TTM)$0.00
Profit Margin0.19%
Operating Margin8.53%
Return on Equity (ROE)4.05%
Debt to Equity2.76
50-Day MA$6.18
200-Day MA$7.07
52-Week Change58.22%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Xeris Biopharma Holdings

What is the current stock price for XERS?

As of the latest trading session, XERS stock trades at $6.79. The 52-week range is $4.30–$10.08, with a day range of $6.79–$7.08.

What is the P/E ratio for XERS?

Xeris Biopharma Holdings's trailing P/E ratio is 2181.0, meaning investors pay $2181.0 for every $1 of annual earnings.

Does XERS pay dividends?

Xeris Biopharma Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XERS?

Analyst ratings and recommendations for XERS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of XERS?

Xeris Biopharma Holdings's market capitalization is $1.22B, classifying it as a small-cap company..